We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Structural Changes Modulate Cell Adhesion

By Biotechdaily staff writers
Posted on 30 Jan 2004
Researchers have used x-ray crystallography techniques to elucidate structural changes that occur when the membrane protein vinculin binds to other proteins such as talin and actin.

Vinculin is a 117 kDa protein localized to focal adhesions. More...
The globular head region of vinculin (Vh) contains the binding sites for talin and alpha-actinin, whereas its rod-like tail domain (Vt) contains the binding sites for F-actin and paxillin. The crystal structure of Vt features a bundle of five amphipathic helices and a C-terminal arm, which emerges as a hydrophobic hairpin surrounded by a collar of basic residues. Vinculin is a conserved component and an essential regulator of both cell (cadherin-mediated) and cell-matrix (integrin–talin-mediated focal adhesions) junctions, and it anchors these adhesion complexes to the actin cytoskeleton by binding to talin in integrin complexes or to alpha-actinin in cadherin junctions.

Talin is a 270 kDa actin-binding protein that localizes to focal adhesions. Two talin molecules form a homodimer with an antiparallel orientation. Proteolysis with thrombin divides talin into an N-terminal head domain and a C-terminal rod domain. The C-terminal rod domain binds to the focal adhesion protein F-actin and to vinculin.

Investigators at St. Jude Children's Research Hospital (Memphis, TN, USA) wrote in the January 8, 2004, issue of Nature that talin binding induced marked conformational changes in Vh, creating a novel helical bundle structure, and this alteration actively displaced Vt from Vh. These results, as well as the ability of alpha-actinin to also bind to Vh and displace Vt from pre-existing Vh-Vt complexes, supported a model whereby Vh functioned as a domain that underwent marked structural changes that allowed vinculin to direct cytoskeletal assembly in focal adhesions and adherens junctions.

"Vinculin is a critical protein that performs different roles in the body,” explained senior author Dr. Philippe R.J. Bois, professor of genetics at St. Jude Children's Research Hospital. "It is a master conductor of much of the cell's life, changing its shape to conduct the cell's business according to the cell's immediate needs.”




Related Links:
St. Jude Children's Research Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.